Sogroya (somapacitan)

pCPA File Number: 22502
Negotiation Status:
Under consideration for negotiation
Indication(s):
Growth hormone deficiency
Sponsor/Manufacturer:
Novo Nordisk Canada Inc.
CADTH Project Number:
SR0779-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable